Print

FDA Puts Achillion Pharmaceuticals, Inc. (ACHN) Hepatitis C Drug on Clinical Hold  
7/2/2013 6:03:00 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Achillion Pharmaceuticals Inc. (ACHN) said U.S. regulators put a hold on a clinical trial of one of the company’s experimental drugs for hepatitis C after some patients experienced elevated liver enzymes. The company’s shares declined in extended trading after the announcement.

Help employers find you! Check out all the jobs and post your resume.

//-->